Industry Research Reports
Home > Reports > Chemical & Material > Global Amlodipine Besilate Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Amlodipine Besilate Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Chemical & Material
Published Date: 2025-02-21
Pages: 91 Pages
Report ld: 4162353
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Amlodipine Besilate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Amlodipine is a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle.
The North America Amlodipine Besilate market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Amlodipine Besilate include Arch Pharmalabs, Century Pharmaceutical, VPL Chemicals, Rakshit Drugs, Moehs, Dr. Reddy's, Cadila Pharmaceuticals, Amsal Chem, Changzhou Yabang Pharmaceutical, Cipla, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Amlodipine Besilate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Amlodipine Besilate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
By Company
- Arch Pharmalabs
- Century Pharmaceutical
- VPL Chemicals
- Rakshit Drugs
- Moehs
- Dr. Reddy's
- Cadila Pharmaceuticals
- Amsal Chem
- Changzhou Yabang Pharmaceutical
- Cipla
- Tapi Teva
- Suanfarma
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity≥98%
- Purity≥99%
Segment by Application
- Amlodipine Besilate Tablets
- Amlodipine Besilate Capsule
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales and revenue of Amlodipine Besilate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Amlodipine Besilate manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Amlodipine Besilate revenue, gross margin, and recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Sales channels analysis
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Amlodipine Besilate Product Scope
1.2 Amlodipine Besilate by Type
1.2.1 Global Amlodipine Besilate Sales by Type (2020 & 2024 & 2031)
1.2.2 Purity≥98%
1.2.3 Purity≥99%
1.3 Amlodipine Besilate by Application
1.3.1 Global Amlodipine Besilate Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Amlodipine Besilate Tablets
1.3.3 Amlodipine Besilate Capsule
1.4 Global Amlodipine Besilate Market Estimates and Forecasts (2020-2031)
1.4.1 Global Amlodipine Besilate Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Amlodipine Besilate Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Amlodipine Besilate Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Amlodipine Besilate Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Amlodipine Besilate Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Amlodipine Besilate Sales Market Share by Region (2020-2025)
2.2.2 Global Amlodipine Besilate Revenue Market Share by Region (2020-2025)
2.3 Global Amlodipine Besilate Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Amlodipine Besilate Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Amlodipine Besilate Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Amlodipine Besilate Market Size and Prospective (2020-2031)
2.4.2 Europe Amlodipine Besilate Market Size and Prospective (2020-2031)
2.4.3 China Amlodipine Besilate Market Size and Prospective (2020-2031)
2.4.4 Japan Amlodipine Besilate Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Amlodipine Besilate Historic Market Review by Type (2020-2025)
3.1.1 Global Amlodipine Besilate Sales by Type (2020-2025)
3.1.2 Global Amlodipine Besilate Revenue by Type (2020-2025)
3.1.3 Global Amlodipine Besilate Price by Type (2020-2025)
3.2 Global Amlodipine Besilate Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Amlodipine Besilate Sales Forecast by Type (2026-2031)
3.2.2 Global Amlodipine Besilate Revenue Forecast by Type (2026-2031)
3.2.3 Global Amlodipine Besilate Price Forecast by Type (2026-2031)
3.3 Different Types Amlodipine Besilate Representative Players
4 Global Market Size by Application
4.1 Global Amlodipine Besilate Historic Market Review by Application (2020-2025)
4.1.1 Global Amlodipine Besilate Sales by Application (2020-2025)
4.1.2 Global Amlodipine Besilate Revenue by Application (2020-2025)
4.1.3 Global Amlodipine Besilate Price by Application (2020-2025)
4.2 Global Amlodipine Besilate Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Amlodipine Besilate Sales Forecast by Application (2026-2031)
4.2.2 Global Amlodipine Besilate Revenue Forecast by Application (2026-2031)
4.2.3 Global Amlodipine Besilate Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Amlodipine Besilate Application
5 Competition Landscape by Players
5.1 Global Amlodipine Besilate Sales by Players (2020-2025)
5.2 Global Top Amlodipine Besilate Players by Revenue (2020-2025)
5.3 Global Amlodipine Besilate Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amlodipine Besilate as of 2024)
5.4 Global Amlodipine Besilate Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Amlodipine Besilate, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Amlodipine Besilate, Product Type & Application
5.7 Global Key Manufacturers of Amlodipine Besilate, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Amlodipine Besilate Sales by Company
6.1.1.1 North America Amlodipine Besilate Sales by Company (2020-2025)
6.1.1.2 North America Amlodipine Besilate Revenue by Company (2020-2025)
6.1.2 North America Amlodipine Besilate Sales Breakdown by Type (2020-2025)
6.1.3 North America Amlodipine Besilate Sales Breakdown by Application (2020-2025)
6.1.4 North America Amlodipine Besilate Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Amlodipine Besilate Sales by Company
6.2.1.1 Europe Amlodipine Besilate Sales by Company (2020-2025)
6.2.1.2 Europe Amlodipine Besilate Revenue by Company (2020-2025)
6.2.2 Europe Amlodipine Besilate Sales Breakdown by Type (2020-2025)
6.2.3 Europe Amlodipine Besilate Sales Breakdown by Application (2020-2025)
6.2.4 Europe Amlodipine Besilate Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Amlodipine Besilate Sales by Company
6.3.1.1 China Amlodipine Besilate Sales by Company (2020-2025)
6.3.1.2 China Amlodipine Besilate Revenue by Company (2020-2025)
6.3.2 China Amlodipine Besilate Sales Breakdown by Type (2020-2025)
6.3.3 China Amlodipine Besilate Sales Breakdown by Application (2020-2025)
6.3.4 China Amlodipine Besilate Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Amlodipine Besilate Sales by Company
6.4.1.1 Japan Amlodipine Besilate Sales by Company (2020-2025)
6.4.1.2 Japan Amlodipine Besilate Revenue by Company (2020-2025)
6.4.2 Japan Amlodipine Besilate Sales Breakdown by Type (2020-2025)
6.4.3 Japan Amlodipine Besilate Sales Breakdown by Application (2020-2025)
6.4.4 Japan Amlodipine Besilate Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Arch Pharmalabs
7.1.1 Arch Pharmalabs Company Information
7.1.2 Arch Pharmalabs Business Overview
7.1.3 Arch Pharmalabs Amlodipine Besilate Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Arch Pharmalabs Amlodipine Besilate Products Offered
7.1.5 Arch Pharmalabs Recent Development
7.2 Century Pharmaceutical
7.2.1 Century Pharmaceutical Company Information
7.2.2 Century Pharmaceutical Business Overview
7.2.3 Century Pharmaceutical Amlodipine Besilate Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Century Pharmaceutical Amlodipine Besilate Products Offered
7.2.5 Century Pharmaceutical Recent Development
7.3 VPL Chemicals
7.3.1 VPL Chemicals Company Information
7.3.2 VPL Chemicals Business Overview
7.3.3 VPL Chemicals Amlodipine Besilate Sales, Revenue and Gross Margin (2020-2025)
7.3.4 VPL Chemicals Amlodipine Besilate Products Offered
7.3.5 VPL Chemicals Recent Development
7.4 Rakshit Drugs
7.4.1 Rakshit Drugs Company Information
7.4.2 Rakshit Drugs Business Overview
7.4.3 Rakshit Drugs Amlodipine Besilate Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Rakshit Drugs Amlodipine Besilate Products Offered
7.4.5 Rakshit Drugs Recent Development
7.5 Moehs
7.5.1 Moehs Company Information
7.5.2 Moehs Business Overview
7.5.3 Moehs Amlodipine Besilate Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Moehs Amlodipine Besilate Products Offered
7.5.5 Moehs Recent Development
7.6 Dr. Reddy's
7.6.1 Dr. Reddy's Company Information
7.6.2 Dr. Reddy's Business Overview
7.6.3 Dr. Reddy's Amlodipine Besilate Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Dr. Reddy's Amlodipine Besilate Products Offered
7.6.5 Dr. Reddy's Recent Development
7.7 Cadila Pharmaceuticals
7.7.1 Cadila Pharmaceuticals Company Information
7.7.2 Cadila Pharmaceuticals Business Overview
7.7.3 Cadila Pharmaceuticals Amlodipine Besilate Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Cadila Pharmaceuticals Amlodipine Besilate Products Offered
7.7.5 Cadila Pharmaceuticals Recent Development
7.8 Amsal Chem
7.8.1 Amsal Chem Company Information
7.8.2 Amsal Chem Business Overview
7.8.3 Amsal Chem Amlodipine Besilate Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Amsal Chem Amlodipine Besilate Products Offered
7.8.5 Amsal Chem Recent Development
7.9 Changzhou Yabang Pharmaceutical
7.9.1 Changzhou Yabang Pharmaceutical Company Information
7.9.2 Changzhou Yabang Pharmaceutical Business Overview
7.9.3 Changzhou Yabang Pharmaceutical Amlodipine Besilate Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Changzhou Yabang Pharmaceutical Amlodipine Besilate Products Offered
7.9.5 Changzhou Yabang Pharmaceutical Recent Development
7.10 Cipla
7.10.1 Cipla Company Information
7.10.2 Cipla Business Overview
7.10.3 Cipla Amlodipine Besilate Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Cipla Amlodipine Besilate Products Offered
7.10.5 Cipla Recent Development
7.11 Tapi Teva
7.11.1 Tapi Teva Company Information
7.11.2 Tapi Teva Business Overview
7.11.3 Tapi Teva Amlodipine Besilate Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Tapi Teva Amlodipine Besilate Products Offered
7.11.5 Tapi Teva Recent Development
7.12 Suanfarma
7.12.1 Suanfarma Company Information
7.12.2 Suanfarma Business Overview
7.12.3 Suanfarma Amlodipine Besilate Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Suanfarma Amlodipine Besilate Products Offered
7.12.5 Suanfarma Recent Development
8 Amlodipine Besilate Manufacturing Cost Analysis
8.1 Amlodipine Besilate Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Amlodipine Besilate
8.4 Amlodipine Besilate Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Amlodipine Besilate Distributors List
9.3 Amlodipine Besilate Customers
10 Amlodipine Besilate Market Dynamics
10.1 Amlodipine Besilate Industry Trends
10.2 Amlodipine Besilate Market Drivers
10.3 Amlodipine Besilate Market Challenges
10.4 Amlodipine Besilate Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Amlodipine Besilate Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Amlodipine Besilate Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Amlodipine Besilate Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Amlodipine Besilate Sales (MT) by Region (2020-2025)
Table 5. Global Amlodipine Besilate Sales Market Share by Region (2020-2025)
Table 6. Global Amlodipine Besilate Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Amlodipine Besilate Revenue Share by Region (2020-2025)
Table 8. Global Amlodipine Besilate Sales (MT) Forecast by Region (2026-2031)
Table 9. Global Amlodipine Besilate Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Amlodipine Besilate Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Amlodipine Besilate Revenue Share Forecast by Region (2026-2031)
Table 12. Global Amlodipine Besilate Sales by Type (MT) & (2020-2025)
Table 13. Global Amlodipine Besilate Sales Share by Type (2020-2025)
Table 14. Global Amlodipine Besilate Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Amlodipine Besilate Price by Type (USD/Kg) & (2020-2025)
Table 16. Global Amlodipine Besilate Sales by Type (MT) & (2026-2031)
Table 17. Global Amlodipine Besilate Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Amlodipine Besilate Price by Type (USD/Kg) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Amlodipine Besilate Sales by Application (MT) & (2020-2025)
Table 21. Global Amlodipine Besilate Sales Share by Application (2020-2025)
Table 22. Global Amlodipine Besilate Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Amlodipine Besilate Price by Application (USD/Kg) & (2020-2025)
Table 24. Global Amlodipine Besilate Sales by Application (MT) & (2026-2031)
Table 25. Global Amlodipine Besilate Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Amlodipine Besilate Price by Application (USD/Kg) & (2026-2031)
Table 27. New Sources of Growth in Amlodipine Besilate Application
Table 28. Global Amlodipine Besilate Sales by Company (MT) & (2020-2025)
Table 29. Global Amlodipine Besilate Sales Share by Company (2020-2025)
Table 30. Global Amlodipine Besilate Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Amlodipine Besilate Revenue Share by Company (2020-2025)
Table 32. Global Amlodipine Besilate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amlodipine Besilate as of 2024)
Table 33. Global Market Amlodipine Besilate Average Price by Company (USD/Kg) & (2020-2025)
Table 34. Global Key Manufacturers of Amlodipine Besilate, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Amlodipine Besilate, Product Type & Application
Table 36. Global Key Manufacturers of Amlodipine Besilate, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Amlodipine Besilate Sales by Company (2020-2025) & (MT)
Table 39. North America Amlodipine Besilate Sales Market Share by Company (2020-2025)
Table 40. North America Amlodipine Besilate Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Amlodipine Besilate Revenue Market Share by Company (2020-2025)
Table 42. North America Amlodipine Besilate Sales by Type (2020-2025) & (MT)
Table 43. North America Amlodipine Besilate Sales Market Share by Type (2020-2025)
Table 44. North America Amlodipine Besilate Sales by Application (2020-2025) & (MT)
Table 45. North America Amlodipine Besilate Sales Market Share by Application (2020-2025)
Table 46. Europe Amlodipine Besilate Sales by Company (2020-2025) & (MT)
Table 47. Europe Amlodipine Besilate Sales Market Share by Company (2020-2025)
Table 48. Europe Amlodipine Besilate Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Amlodipine Besilate Revenue Market Share by Company (2020-2025)
Table 50. Europe Amlodipine Besilate Sales by Type (2020-2025) & (MT)
Table 51. Europe Amlodipine Besilate Sales Market Share by Type (2020-2025)
Table 52. Europe Amlodipine Besilate Sales by Application (2020-2025) & (MT)
Table 53. Europe Amlodipine Besilate Sales Market Share by Application (2020-2025)
Table 54. China Amlodipine Besilate Sales by Company (2020-2025) & (MT)
Table 55. China Amlodipine Besilate Sales Market Share by Company (2020-2025)
Table 56. China Amlodipine Besilate Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Amlodipine Besilate Revenue Market Share by Company (2020-2025)
Table 58. China Amlodipine Besilate Sales by Type (2020-2025) & (MT)
Table 59. China Amlodipine Besilate Sales Market Share by Type (2020-2025)
Table 60. China Amlodipine Besilate Sales by Application (2020-2025) & (MT)
Table 61. China Amlodipine Besilate Sales Market Share by Application (2020-2025)
Table 62. Japan Amlodipine Besilate Sales by Company (2020-2025) & (MT)
Table 63. Japan Amlodipine Besilate Sales Market Share by Company (2020-2025)
Table 64. Japan Amlodipine Besilate Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Amlodipine Besilate Revenue Market Share by Company (2020-2025)
Table 66. Japan Amlodipine Besilate Sales by Type (2020-2025) & (MT)
Table 67. Japan Amlodipine Besilate Sales Market Share by Type (2020-2025)
Table 68. Japan Amlodipine Besilate Sales by Application (2020-2025) & (MT)
Table 69. Japan Amlodipine Besilate Sales Market Share by Application (2020-2025)
Table 70. Arch Pharmalabs Company Information
Table 71. Arch Pharmalabs Description and Business Overview
Table 72. Arch Pharmalabs Amlodipine Besilate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 73. Arch Pharmalabs Amlodipine Besilate Product
Table 74. Arch Pharmalabs Recent Development
Table 75. Century Pharmaceutical Company Information
Table 76. Century Pharmaceutical Description and Business Overview
Table 77. Century Pharmaceutical Amlodipine Besilate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 78. Century Pharmaceutical Amlodipine Besilate Product
Table 79. Century Pharmaceutical Recent Development
Table 80. VPL Chemicals Company Information
Table 81. VPL Chemicals Description and Business Overview
Table 82. VPL Chemicals Amlodipine Besilate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 83. VPL Chemicals Amlodipine Besilate Product
Table 84. VPL Chemicals Recent Development
Table 85. Rakshit Drugs Company Information
Table 86. Rakshit Drugs Description and Business Overview
Table 87. Rakshit Drugs Amlodipine Besilate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 88. Rakshit Drugs Amlodipine Besilate Product
Table 89. Rakshit Drugs Recent Development
Table 90. Moehs Company Information
Table 91. Moehs Description and Business Overview
Table 92. Moehs Amlodipine Besilate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 93. Moehs Amlodipine Besilate Product
Table 94. Moehs Recent Development
Table 95. Dr. Reddy's Company Information
Table 96. Dr. Reddy's Description and Business Overview
Table 97. Dr. Reddy's Amlodipine Besilate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 98. Dr. Reddy's Amlodipine Besilate Product
Table 99. Dr. Reddy's Recent Development
Table 100. Cadila Pharmaceuticals Company Information
Table 101. Cadila Pharmaceuticals Description and Business Overview
Table 102. Cadila Pharmaceuticals Amlodipine Besilate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 103. Cadila Pharmaceuticals Amlodipine Besilate Product
Table 104. Cadila Pharmaceuticals Recent Development
Table 105. Amsal Chem Company Information
Table 106. Amsal Chem Description and Business Overview
Table 107. Amsal Chem Amlodipine Besilate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 108. Amsal Chem Amlodipine Besilate Product
Table 109. Amsal Chem Recent Development
Table 110. Changzhou Yabang Pharmaceutical Company Information
Table 111. Changzhou Yabang Pharmaceutical Description and Business Overview
Table 112. Changzhou Yabang Pharmaceutical Amlodipine Besilate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 113. Changzhou Yabang Pharmaceutical Amlodipine Besilate Product
Table 114. Changzhou Yabang Pharmaceutical Recent Development
Table 115. Cipla Company Information
Table 116. Cipla Description and Business Overview
Table 117. Cipla Amlodipine Besilate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 118. Cipla Amlodipine Besilate Product
Table 119. Cipla Recent Development
Table 120. Tapi Teva Company Information
Table 121. Tapi Teva Description and Business Overview
Table 122. Tapi Teva Amlodipine Besilate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 123. Tapi Teva Amlodipine Besilate Product
Table 124. Tapi Teva Recent Development
Table 125. Suanfarma Company Information
Table 126. Suanfarma Description and Business Overview
Table 127. Suanfarma Amlodipine Besilate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 128. Suanfarma Amlodipine Besilate Product
Table 129. Suanfarma Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Amlodipine Besilate Distributors List
Table 133. Amlodipine Besilate Customers List
Table 134. Amlodipine Besilate Market Trends
Table 135. Amlodipine Besilate Market Drivers
Table 136. Amlodipine Besilate Market Challenges
Table 137. Amlodipine Besilate Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Amlodipine Besilate Product Picture
Figure 2. Global Amlodipine Besilate Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Amlodipine Besilate Sales Market Share by Type in 2024 & 2031
Figure 4. Purity≥98% Product Picture
Figure 5. Purity≥99% Product Picture
Figure 6. Global Amlodipine Besilate Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Amlodipine Besilate Sales Market Share by Application in 2024 & 2031
Figure 8. Amlodipine Besilate Tablets Examples
Figure 9. Amlodipine Besilate Capsule Examples
Figure 10. Global Amlodipine Besilate Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Amlodipine Besilate Sales Growth Rate (2020-2031) & (US$ Million)
Figure 12. Global Amlodipine Besilate Sales (MT) Growth Rate (2020-2031)
Figure 13. Global Amlodipine Besilate Price Trends Growth Rate (2020-2031) & (USD/Kg)
Figure 14. Amlodipine Besilate Report Years Considered
Figure 15. Global Market Amlodipine Besilate Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 16. Global Amlodipine Besilate Revenue Market Share by Region: 2020 VS 2024
Figure 17. North America Amlodipine Besilate Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. North America Amlodipine Besilate Sales (MT) Growth Rate (2020-2031)
Figure 19. Europe Amlodipine Besilate Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Europe Amlodipine Besilate Sales (MT) Growth Rate (2020-2031)
Figure 21. China Amlodipine Besilate Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. China Amlodipine Besilate Sales (MT) Growth Rate (2020-2031)
Figure 23. Japan Amlodipine Besilate Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Japan Amlodipine Besilate Sales (MT) Growth Rate (2020-2031)
Figure 25. Global Amlodipine Besilate Revenue Share by Type (2020-2025)
Figure 26. Global Amlodipine Besilate Sales Share by Type (2026-2031)
Figure 27. Global Amlodipine Besilate Revenue Share by Type (2026-2031)
Figure 28. Global Amlodipine Besilate Revenue Share by Application (2020-2025)
Figure 29. Global Amlodipine Besilate Revenue Growth Rate by Application in 2020 & 2024
Figure 30. Global Amlodipine Besilate Sales Share by Application (2026-2031)
Figure 31. Global Amlodipine Besilate Revenue Share by Application (2026-2031)
Figure 32. Global Amlodipine Besilate Sales Share by Company (2024)
Figure 33. Global Amlodipine Besilate Revenue Share by Company (2024)
Figure 34. Global 5 Largest Amlodipine Besilate Players Market Share by Revenue in Amlodipine Besilate: 2020 & 2024
Figure 35. Amlodipine Besilate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 36. Manufacturing Cost Structure of Amlodipine Besilate
Figure 37. Manufacturing Process Analysis of Amlodipine Besilate
Figure 38. Amlodipine Besilate Industrial Chain
Figure 39. Channels of Distribution (Direct Vs Distribution)
Figure 40. Distributors Profiles
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Amlodipine Besilate market?
The top companies in the global Amlodipine Besilate market are Arch Pharmalabs、Century Pharmaceutical、VPL Chemicals.
Related Reports
Amlodipine Besilate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Amlodipine Besilate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 144
USD 3950.00
(Single User License)
Global Amlodipine Besilate Market Research Report 2026
The global Amlodipine Besilate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-25
Pages: 140
USD 2900.00
(Single User License)
Global Amlodipine Besilate Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Amlodipine Besilate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 167
USD 4900.00
(Single User License)
Global Amlodipine Besilate Market Research Report 2025
The global market for Amlodipine Besilate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-21
Pages: 100
USD 2900.00
(Single User License)
Amlodipine Besilate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Amlodipine Besilate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 121
USD 3950.00
(Single User License)
Global Amlodipine Besilate Market Insights, Forecast to 2030
Amlodipine is a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle.
Published Date: 2024-04-16
Pages: 108
USD 4900.00
(Single User License)
Amlodipine Besilate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Amlodipine is a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle.
Published Date: 2024-01-25
Pages: 115
USD 3950.00
(Single User License)
Global Amlodipine Besilate Market Research Report 2024
Amlodipine is a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle.
Published Date: 2024-01-11
Pages: 96
USD 2900.00
(Single User License)
Amlodipine Besilate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Amlodipine Besilate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 144
USD 3950.00 (Single User License)Global Amlodipine Besilate Market Research Report 2026
The global Amlodipine Besilate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-25
Pages: 140
USD 2900.00 (Single User License)Global Amlodipine Besilate Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Amlodipine Besilate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 167
USD 4900.00 (Single User License)Global Amlodipine Besilate Market Research Report 2025
The global market for Amlodipine Besilate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-21
Pages: 100
USD 2900.00 (Single User License)Amlodipine Besilate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Amlodipine Besilate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 121
USD 3950.00 (Single User License)Global Amlodipine Besilate Market Insights, Forecast to 2030
Amlodipine is a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle.
Published: 2024-04-16
Pages: 108
USD 4900.00 (Single User License)Amlodipine Besilate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Amlodipine is a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle.
Published: 2024-01-25
Pages: 115
USD 3950.00 (Single User License)Global Amlodipine Besilate Market Research Report 2024
Amlodipine is a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle.
Published: 2024-01-11
Pages: 96
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now